Sara Colella
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sara Colella has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Amina Antonacci
Institute of Crystallography, Department of Chemical Sciences and Materials Technologies, National Research Council, Monterotondo, Rome, Italy
1 shared publication- Amina Antonacci
Institute of Crystallography, Department of Chemical Sciences and Materials Technologies, National Research Council, Via Salaria km 29.300, Monterotondo, 00015 Rome, Italy
1 shared publication - Annalisa Masi
Istituto di Cristallografia, Consiglio Nazionale delle Ricerche, Via Salaria km 29.300, 00015 Monterotondo, Italy
1 shared publication Bruno Miranda
Institute of Applied Sciences and Intelligent Systems, Department of Physical Sciences and Technologies of Matter, National Research Council, Naples, Italy
1 shared publication- Federica Musella
Department of Biology, University of Naples Federico II, Complesso Universitario Monte S. Angelo, Via Cinthia 4, 80126 Naples, Italy
1 shared publication Gabriella Fiorentino
Department of Biology, University of Naples Federico II, Complesso Universitario Monte S. Angelo, Naples, Italy
1 shared publication
Latest Publications
- Open Access
- 23 June 2026
- Published by Springer Nature in Bioscience Nanotechnology
- Vol. 2 (1) , 16
Nanotechnology-driven evolution of isothermal amplification diagnostics
- 23 June 2026
- Published by Springer Nature in Bioscience Nanotechnology
- Vol. 2 (1) , 16
Open AccessNanotechnology-driven evolution of isothermal amplification diagnostics
- Open Access
- 19 December 2025
- Published by MDPI AG in Marine Drugs
- Vol. 24 (1) , 1
CRISPR-Cas Technology Turns Chlamydomonas reinhardtii into a Flagship for Algal Biotechnology
Microalgae represent some of the most promising eukaryotic platforms in biotechnology due to their rapid growth, simple cultivation requirements, reliance on sunlight as a primary energy source, and ability to synthesize high-value bioactive compounds. These characteristics have made microalgae attractive candidates in various fields, including biofuel production, carbon capture, and pharmaceutical development. However, several technical limitations have limited their large-scale use as sustainable biofactories. A paradigm shift is currently occurring thanks to the genetic manipulation of microalgae, driven by CRISPR-Cas technology. Significant progress has been made in the model species Chlamydomonas reinhardtii, particularly in the targeted and efficient insertion of foreign DNA. Despite this progress, key challenges remain, and further optimization of CRISPR-Cas methodologies is needed to fully unleash the genetic potential of this organism. This review provides an overview of the convergence of CRISPR-Cas technologies in microalgae research, highlighting their impact on genetic studies, metabolic engineering, and industrial applications. It summarizes recent advances in microalgal genome editing through CRISPR systems, outlines current technical challenges, and highlights future directions for improving the implementation of this innovative technology in microalgal biotechnology.
- 19 December 2025
- Published by MDPI AG in Marine Drugs
- Vol. 24 (1) , 1
Open AccessCRISPR-Cas Technology Turns Chlamydomonas reinhardtii into a Flagship for Algal Biotechnology
Microalgae represent some of the most promising eukaryotic platforms in biotechnology due to their rapid growth, simple cultivation requirements, reliance on sunlight as a primary energy source, and ability to synthesize high-value bioactive compounds. These characteristics have made microalgae attractive candidates in various fields, including biofuel production, carbon capture, and pharmaceutical development. However, several technical limitations have limited their large-scale use as sustainable biofactories. A paradigm shift is currently occurring thanks to the genetic manipulation of microalgae, driven by CRISPR-Cas technology. Significant progress has been made in the model species Chlamydomonas reinhardtii, particularly in the targeted and efficient insertion of foreign DNA. Despite this progress, key challenges remain, and further optimization of CRISPR-Cas methodologies is needed to fully unleash the genetic potential of this organism. This review provides an overview of the convergence of CRISPR-Cas technologies in microalgae research, highlighting their impact on genetic studies, metabolic engineering, and industrial applications. It summarizes recent advances in microalgal genome editing through CRISPR systems, outlines current technical challenges, and highlights future directions for improving the implementation of this innovative technology in microalgal biotechnology.